Skandinaviska Enskilda Banken (SEB)’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-32,600
| Closed | -$2.21M | – | 982 |
|
|
2019
Q3 | $2.21M | Sell |
32,600
-11,600
| -26% | -$787K | 0.02% | 514 |
|
|
2019
Q2 | $2.57M | Buy |
44,200
+2,900
| +7% | +$169K | 0.02% | 445 |
|
|
2019
Q1 | $2.89M | Sell |
41,300
-600
| -1% | -$42K | 0.03% | 384 |
|
|
2018
Q4 | $2.7M | Sell |
41,900
-13,300
| -24% | -$857K | 0.02% | 392 |
|
|
2018
Q3 | $3.88M | Buy |
55,200
+5,900
| +12% | +$414K | 0.03% | 345 |
|
|
2018
Q2 | $2.49M | Sell |
49,300
-29,200
| -37% | -$1.47M | 0.02% | 387 |
|
|
2018
Q1 | $2.46M | Sell |
78,500
-12,400
| -14% | -$388K | 0.02% | 347 |
|
|
2017
Q4 | $3.11M | Sell |
90,900
-7,500
| -8% | -$257K | 0.03% | 352 |
|
|
2017
Q3 | $3.16M | Hold |
98,400
| – | – | 0.03% | 370 |
|
|
2017
Q2 | $3.2M | Sell |
98,400
-20,100
| -17% | -$654K | 0.03% | 371 |
|
|
2017
Q1 | $3.73M | Sell |
118,500
-4,200
| -3% | -$132K | 0.04% | 332 |
|
|
2016
Q4 | $3.61M | Sell |
122,700
-6,200
| -5% | -$182K | 0.04% | 286 |
|
|
2016
Q3 | $3.73M | Buy |
128,900
+66,900
| +108% | +$1.93M | 0.04% | 309 |
|
|
2016
Q2 | $1.61M | Buy |
62,000
+35,800
| +137% | +$927K | 0.02% | 507 |
|
|
2016
Q1 | $649K | Sell |
26,200
-49,400
| -65% | -$1.22M | 0.01% | 620 |
|
|
2015
Q4 | $2.66M | Buy |
+75,600
| New | +$2.66M | 0.03% | 317 |
|